Lyme disease vaccine cleared for marketing.
Miller
J L
JL
D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D015748:Borrelia burgdorferi Group / Q000276:immunology*; D017277:Drug Approval; D006801:Humans; D008074:Lipoproteins; D008193:Lyme Disease / Q000517:prevention & control*; D014481:United States; D014486:United States Food and Drug Administration
D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D008074:Lipoproteins; C072045:OspA protein